Healthcare Distribution

Healthcare Distribution

Global Healthcare Distribution Market to Reach $3.2 Trillion by 2027
In the changed post COVID-19 business landscape, the global market for Healthcare Distribution estimated at US$876.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Trillion by 2027, growing at a CAGR of 20.2% over the analysis period 2020-2027. Pharmaceutical, one of the segments analyzed in the report, is projected to record a 19.9% CAGR and reach US$1.3 Trillion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biopharmaceutical segment is readjusted to a revised 22.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $305 Billion, While China is Forecast to Grow at 22.2% CAGR
The Healthcare Distribution market in the U.S. is estimated at US$305 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$561.3 Billion by the year 2027 trailing a CAGR of 22.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 18.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 20.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$398.3 Billion by the year 2027.

Medical Devices Segment to Record 17.2% CAGR
In the global Medical Devices segment, USA, Canada, Japan, China and Europe will drive the 17.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$169.4 Billion in the year 2020 will reach a projected size of US$510.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 17.4% CAGR through the analysis period.

Select Competitors (Total 61 Featured) -

  • Accord-UK Ltd.
  • ALLIANCE UNICHEM IP LIMITED
  • AmerisourceBergen Corporation
  • Attain Med, Inc.
  • Cardinal Health, Inc.
  • CuraScript SD
  • Dakota Drug, Inc.
  • Express Scripts Holding Company
  • FedEx Corporation
  • FFF Enterprises, Inc.
  • Henry Schein Inc.
  • KeySource Medical, Inc.
  • McKesson Corporation
  • Medline Industries
  • Morris and Dickson Co., LLC
  • Mutual Drug
  • Owens & Minor, Inc.
  • Patterson Companies Inc.
  • PHOENIX Group
  • Redington (India) Limited
  • Shanghai Pharmaceutical Group Co., Ltd.
  • Smith Drug Company
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Healthcare Distribution – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
The Race Between the Virus & Vaccines Intensifies. Amidst this Chaotic Battle, Where is the World Economy Headed in 2021?
How Fast the World is Vaccinated Will Determine How Soon the Pandemic Will End: Global Number of Annual COVID-19 Vaccine Doses (In Million) for Years 2020 through 2025 by Geographic Region/Country
Progress on Vaccinations, Why Should Businesses Care?
These are Times When Questions Abound & Answers Are Few
With IMF’s Upward Revision of Global GDP Forecasts for 2021, Most Companies Are Bullish About a Global Economic Comeback.
A Strong 2021 Economic Rebound Based On Pent-Up Demand Comes as a Relief for Suffering Industries & Markets: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Easing Unemployment Levels in 2021 Although Moderate Will Infuse Hope for Industries Reliant on Consumer Discretionary Incomes: Global Number of Unemployed People (In Million) for Years 2017, 2019, 2020, and 2022
A Retrospective Review of Year 2020 as the Worst Year in Humanity’s History that Left the World in Shambles & Industries and Markets Upended
How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What’s the New Normal?
The Biggest & Worst Ever Public Health Crisis in Human History Creates a Mixed Bag of Challenges & Opportunities for the Healthcare Industry
With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
Clinical Diagnostic Laboratories Work Overtime to Manage Giant Waves of COVID Infection Testing Flowing In
Global Clinical Diagnostics Market Reset & Trajectory - Growth Outlook (In %) For Years 2019 Through 2025
The Pandemic Triggers Shift in Consumer Behavior & Engagement With Healthcare Technologies & Services
Healthcare Industry Pushed to Adopt Digital Technologies & Innovate to Save Lives Amid the Crisis
Digital Health Technologies Poised to Break New Grounds Post Pandemic: Global Opportunity in Digital Health (In US$ Billion) for Years 2020, 2022, 2024 and 2026
How COVID-19 Outbreak Sent the Healthcare Supply Chain Into a Tailspin
Unprecedented Losses Sustained in the Supply Chain Bodes Well for Integration of Emerging Technologies like Blockchain to Enhance Resilience & Reliability: Global Losses in Supply Chain as a % of Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA) in the Year 2020
Far-Flung Supply Chains of the Pharma Industry Cannot be Consolidated Easily & Abruptly, But the Winds of Change Blown by COVID-19 Can Be Felt: Global Number of Plants Registered with the U.S. to Supply Active Pharmaceutical Ingredients as of the Year 2020
Healthcare Supply Chain Management Storms Into the Spotlight to Address Disruptions Posed by the Crisis
With Smart Management of Supply Chains Being the Need of the Hour, Healthcare Supply Chain Management to Reach New Highs: Global Opportunity in Healthcare Supply Chain Management (In US$ Million) for Years 2020, 2022, 2024, 2026
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Substandard Drugs, an Urgent Challenge in the Supply Chain that Begs to be Addressed
Pharmaceutical Thefts & Counterfeiting, A Persistent Challenge in Distribution That Eludes Resolution
Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
Storming Into the Spotlight Is the Use of Blockchain in Fighting Counterfeiting of Drugs
Rising Incidence of Counterfeiting in the Pharmaceutical Industry Pushes Up the Urgency to Leverage the Security Benefits Promised by Blockchain: Global Number of Pharmaceutical Counterfeiting Incidents for Years 2000, 2005, 2010, 2015, 2019 & 2022
Serialization Emerges as an Another Weapon in the Arsenal to Battle Counterfeiting
Rising Healthcare Costs Drives Attractiveness of e-Pharmacies
Here’s How Healthcare Costs Are Outstripping Global GDP: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Social Distancing Amid the COVID-19 Pandemic Accelerates the Viability & Indispensability of e-Pharmacies, Fast Forwarding Growth by Over 2 Years
Global ePharmacy Sales Breakdown (In %) by OTC Drugs & RX Drugs As of the Year 2021
Aging Population, Rising Prevalence of Chronic Diseases & Ensuing Demand for Drugs & Medical Equipment Rank as Major Drivers of Growth in the Market
Aging Population Steps-Up the Burden On Healthcare Systems Including Distribution: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Rising Prevalence of Chronic Diseases Amplifies Demand for Pharmaceutical Drugs & Distribution: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
Robust Demand for Pharmaceutical Drugs Drives Growth in the Market
Pharmaceutical Contract Manufacturing, a Barometer of the Growing Demand & Production of Drugs
More Drugs Being Manufactured Means More Drugs in Distribution: Global Opportunity for Pharmaceutical Contract Manufacturing (In US$ Billion) for Years 2020, 2022, 2024, and 2026
Artificial Intelligence to Revolutionize Pharmaceutical Retailing
As the World Ramps Up Production of COVID-19 Vaccines, Distribution Emerges Into the Spotlight
As Mass Vaccination Drives Kick-in Challenges in Covid-19 Vaccine Distribution Begin to Surface
A Review of Vaccine Distribution Approach in the US
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Biopharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Other End Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 22: USA Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 23: USA Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: USA 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 25: USA Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
CANADA
TABLE 28: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 29: Canada Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: Canada 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 31: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 32: Canada Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: Canada 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
JAPAN
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 34: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 35: Japan Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: Japan 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 37: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 38: Japan Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: Japan 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
CHINA
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 40: China Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 41: China Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: China 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 43: China Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: China Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: China 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
EUROPE
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 46: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 47: Europe Historic Review for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: Europe 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 49: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 50: Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: Europe 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 52: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: Europe 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
FRANCE
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 55: France Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: France Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: France 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 58: France Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 59: France Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: France 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
GERMANY
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 61: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: Germany Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: Germany 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 64: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 65: Germany Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Germany 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
ITALY
TABLE 67: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 68: Italy Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: Italy 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 70: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: Italy Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: Italy 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 73: UK Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: UK Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: UK 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 76: UK Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: UK Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: UK 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
SPAIN
TABLE 79: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 80: Spain Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: Spain 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 82: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Spain Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Spain 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
RUSSIA
TABLE 85: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 86: Russia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: Russia 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 88: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: Russia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: Russia 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 91: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 92: Rest of Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 93: Rest of Europe 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 95: Rest of Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 96: Rest of Europe 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 97: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 98: Asia-Pacific Historic Review for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 99: Asia-Pacific 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 101: Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 102: Asia-Pacific 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 103: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 104: Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 105: Asia-Pacific 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 106: Australia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 107: Australia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 108: Australia 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 109: Australia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 110: Australia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 111: Australia 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
INDIA
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 112: India Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 113: India Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 114: India 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 115: India Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 116: India Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 117: India 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 118: South Korea Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 119: South Korea Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 120: South Korea 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 121: South Korea Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 122: South Korea Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 123: South Korea 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 125: Rest of Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 126: Rest of Asia-Pacific 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 127: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 128: Rest of Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 130: Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 131: Latin America Historic Review for Healthcare Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 132: Latin America 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 133: Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 134: Latin America Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 135: Latin America 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 136: Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 137: Latin America Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 138: Latin America 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
ARGENTINA
TABLE 139: Argentina Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 140: Argentina Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 141: Argentina 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 142: Argentina Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 143: Argentina Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 144: Argentina 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
BRAZIL
TABLE 145: Brazil Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 146: Brazil Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 147: Brazil 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 148: Brazil Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 149: Brazil Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 150: Brazil 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
MEXICO
TABLE 151: Mexico Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 152: Mexico Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 153: Mexico 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 154: Mexico Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 155: Mexico Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 156: Mexico 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 157: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 158: Rest of Latin America Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 159: Rest of Latin America 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 161: Rest of Latin America Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 162: Rest of Latin America 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
MIDDLE EAST
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 163: Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 164: Middle East Historic Review for Healthcare Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 165: Middle East 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
TABLE 166: Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 167: Middle East Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 168: Middle East 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 169: Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 170: Middle East Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 171: Middle East 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
IRAN
TABLE 172: Iran Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 173: Iran Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 174: Iran 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 175: Iran Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 176: Iran Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 177: Iran 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
ISRAEL
TABLE 178: Israel Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 179: Israel Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 180: Israel 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 181: Israel Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 182: Israel Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 183: Israel 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 185: Saudi Arabia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 186: Saudi Arabia 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 187: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 188: Saudi Arabia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 189: Saudi Arabia 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 190: UAE Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 191: UAE Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 192: UAE 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 193: UAE Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 194: UAE Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 195: UAE 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 197: Rest of Middle East Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 198: Rest of Middle East 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 199: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 200: Rest of Middle East Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 201: Rest of Middle East 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
AFRICA
Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 202: Africa Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 203: Africa Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 204: Africa 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2012, 2021 & 2027
TABLE 205: Africa Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 206: Africa Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 207: Africa 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 61

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings